Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Pell Bio-Med Technology

Market Cap: NT$7.4b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

SymBio Pharmaceuticals

Market Cap: JP¥8.0b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

Jubilant Pharmova

Market Cap: ₹169.2b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Beijing Hotgen Biotech

Market Cap: CN¥11.4b

Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.

PharmaResearch

Market Cap: ₩4.6t

Operates as a biopharmaceutical company primarily in South Korea.

Central Pharmaceutical No3

Market Cap: ₫1.2t

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

Jiuzhitang

Market Cap: CN¥7.5b

Provides traditional Chinese, chemical, biological, and health medicine products in China.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

Kidswell Bio

Market Cap: JP¥8.2b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

Harbin Pharmaceutical Group

Market Cap: CN¥9.4b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

Shanghai Innostar Biotechnology

Market Cap: CN¥4.5b

Shanghai Innostar Biotechnology Co., Ltd.

Human Metabolome Technologies

Market Cap: JP¥4.5b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Oscotec

Market Cap: ₩1.0t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Noxopharm

Market Cap: AU$19.9m

A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.

AP Healthcare

Market Cap: ₩67.9b

Distributes pharmaceutical products in South Korea.

Starpharma Holdings

Market Cap: AU$36.0m

A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥7.7b

Provides in-vitro diagnostics products and services in the People’s Republic of China and internationally.

Jiangsu Jibeier Pharmaceutical

Market Cap: CN¥5.0b

A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.

Linical

Market Cap: JP¥6.9b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Jeil Pharma Holdings

Market Cap: ₩125.1b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

Shree Ganesh Remedies

Market Cap: ₹7.8b

Engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India.

Chimeric Therapeutics

Market Cap: AU$9.3m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Livzon Pharmaceutical Group

Market Cap: CN¥29.2b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.

Shaanxi Panlong Pharmaceutical Group Limited By Share

Market Cap: CN¥3.0b

Researches and develops, produces, and sells Chinese patent medicines in China.

Hunan Nucien Pharmaceutical

Market Cap: CN¥1.8b

A pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China.

Deva Holding

Market Cap: ₺11.4b

Manufactures, markets, and sells pharmaceutical products in Turkey.

Danaher

Market Cap: US$133.7b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

MaxCyte

Market Cap: UK£178.1m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Adagene

Market Cap: US$78.2m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Atea Pharmaceuticals

Market Cap: US$240.5m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Orion Oyj

Market Cap: €8.3b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Read-Gene

Market Cap: zł48.8m

Engages in the detection, prevention, and treatment of various types of cancer.

OmniAb

Market Cap: US$174.9m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Société de Therapeutique Marocaine

Market Cap: د.م10.4b

A pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco.

PDS Biotechnology

Market Cap: US$71.7m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Nuvation Bio

Market Cap: US$690.7m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.